Phytochemical and biological investigation of Astragalus Caprinus L.
Astragalus Caprinus
Antimicrobial activity
Antitumor
Flavonoids
Lipid fraction
Journal
BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232
Informations de publication
Date de publication:
01 Aug 2024
01 Aug 2024
Historique:
received:
18
12
2023
accepted:
24
04
2024
medline:
2
8
2024
pubmed:
2
8
2024
entrez:
1
8
2024
Statut:
epublish
Résumé
cultivated and wild plants are used to treat different ailments. The Astragalus genus is found in temperate and dry climates; thus, it is found in Egypt and the arab world. Astragalus caprinus has a good amount of bioactive chemicals, which may help explain its therapeutic effects in reducing the risk of consequences from disease. The phytochemical investigation of the herb and roots of Astragalus caprinus L. included the analytical characterization for the petroleum ether components by GC/MS, unsaponifiable matter (unsap. fraction), and fatty acids (FAME) investigation by GLC analysis. Main flavonoids were chromatographically isolated from ethyl acetate and n-butanol extracts. In vitro antimicrobial activity has been tested against the Gram-positive bacteria Staphylococcus aureus and Streptococcus mutans for different plant extracts, the Gram-negative bacteria Pseudomonas aeruginosa and Klebsiella pneumonia, the fungus Candida albicans and Aspergillus niger, and the Escherichia coli bacterium. Metabolite cytotoxicity was examined using the MTT assay against HepG-2 (human liver carcinoma) and MCF-7 (breast carcinoma). Identifying the important components of the herb and root petroleum ether extracts was achieved. Using column chromatography, luteolin, cosmosiin (apigenin-7-O-glucoside), and cynaroside (luteolin-7-O-glucoside) were separated and identified using UV, NMR, and Mass Spectroscopy. Root extracts displayed potential antimicrobial activity against most of the tested pathogens. Both extracts (herb and roots) were active against the MCF-7 cell line and HepG-2 cell line with IC Astragalus caprinus seems to be a promising source of bioactive compounds that could potentially aid in preventing disease complications and address common health issues in developing countries. Moreover, the various parts of this plant could be utilized as natural raw materials for producing health-boosting products that could address common health issues in developing countries.
Sections du résumé
BACKGROUND
BACKGROUND
cultivated and wild plants are used to treat different ailments. The Astragalus genus is found in temperate and dry climates; thus, it is found in Egypt and the arab world. Astragalus caprinus has a good amount of bioactive chemicals, which may help explain its therapeutic effects in reducing the risk of consequences from disease.
METHOD
METHODS
The phytochemical investigation of the herb and roots of Astragalus caprinus L. included the analytical characterization for the petroleum ether components by GC/MS, unsaponifiable matter (unsap. fraction), and fatty acids (FAME) investigation by GLC analysis. Main flavonoids were chromatographically isolated from ethyl acetate and n-butanol extracts. In vitro antimicrobial activity has been tested against the Gram-positive bacteria Staphylococcus aureus and Streptococcus mutans for different plant extracts, the Gram-negative bacteria Pseudomonas aeruginosa and Klebsiella pneumonia, the fungus Candida albicans and Aspergillus niger, and the Escherichia coli bacterium. Metabolite cytotoxicity was examined using the MTT assay against HepG-2 (human liver carcinoma) and MCF-7 (breast carcinoma).
RESULTS
RESULTS
Identifying the important components of the herb and root petroleum ether extracts was achieved. Using column chromatography, luteolin, cosmosiin (apigenin-7-O-glucoside), and cynaroside (luteolin-7-O-glucoside) were separated and identified using UV, NMR, and Mass Spectroscopy. Root extracts displayed potential antimicrobial activity against most of the tested pathogens. Both extracts (herb and roots) were active against the MCF-7 cell line and HepG-2 cell line with IC
CONCLUSION
CONCLUSIONS
Astragalus caprinus seems to be a promising source of bioactive compounds that could potentially aid in preventing disease complications and address common health issues in developing countries. Moreover, the various parts of this plant could be utilized as natural raw materials for producing health-boosting products that could address common health issues in developing countries.
Identifiants
pubmed: 39090617
doi: 10.1186/s12906-024-04484-4
pii: 10.1186/s12906-024-04484-4
doi:
Substances chimiques
Plant Extracts
0
Phytochemicals
0
Anti-Infective Agents
0
Flavonoids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
294Informations de copyright
© 2024. The Author(s).
Références
Li X, Qu L, Dong Y, Han L, Liu E, Fang S, Zhang Y, Wang T. A review of recent research progress on the Astragalus genus. Molecules. 2014;19(11):18850–80.
doi: 10.3390/molecules191118850
pubmed: 25407722
pmcid: 6270929
Ozenda P. Flora et vegetation du Sahara, 3
Quezel P, Santa S. Nouvelle flore de l’ Algérie et des regions désertiques méridionales. Volume 1–2. Paris, France: CNRS; 1963.
Gill MSA, Saleem H, Ahemad N. Plant extracts and their secondary metabolites as modulators of Kinases. Curr Top Med Chem. 2020;20(12):1093–104. https://doi.org/10.2174/1568026620666200224100219 .
doi: 10.2174/1568026620666200224100219
pubmed: 32091334
Bagci E. Fatty acid composition of some Astragalus species from Turkey. Chem Nat Compd. 2006;42(6):645–8.
doi: 10.1007/s10600-006-0243-y
Yang LP, Shen JG, Xu WC, Li J, Jiang J. Secondary metabolites of the Genus Astragalus: structure and Biological-Activity Update. Q Chem Biodivers. 2013;10(6):1004–54.
doi: 10.1002/cbdv.201100444
Gorai D, Jash SK, Roy R. Flavonoids from Astragalus Genus. Int J Pharm Sci Res. 2019;7(7):2732–47.
Albayrak S, Kaya O. Antioxidant and antimicrobial activities of four Astragalus species growing wild in Turkey. Turkish J Biochem. 2018;43(4):425–34.
doi: 10.1515/tjb-2017-0241
Ghasemian-Yadegari J, Hamedeyazdan S, Nazemiyeh H, Fathiazad F. Evaluation of phytochemical antioxidant and antibacterial activity on Astragalus chrysostachys boiss roots. Iran J Pharm Res Int J Phys Res. 2019;18(4):1902–11.
Xiao CJ, Zhang Y, Qiu L, Dong X, Jiang B. Schistosomicidal and antioxidant flavonoids from Astragalus Englerianus. Planta Med. 2018;80(18):1727–31.
Guo Z, Lou Y, Kong M, Luo Q, Liu Z, Wu J. A systematic review of phytochemistry, pharmacology and pharmacokinetics on Astragali Radix: implications for Astragali Radix as a personalized medicine. Int J Mol Sci. 2019;20(6):1463.
doi: 10.3390/ijms20061463
pubmed: 30909474
pmcid: 6470777
Wang J, Jia J, Song L, Gong X, Xu J, Yang M, Li M. Extraction, structure, and pharmacological activities of Astragalus polysaccharides. Appl Sci. 2019;9(1):122.
doi: 10.3390/app9010122
Finar IL. (1967). Organic chemistry. 5th ed. London, Longmans Green and Co. Ltd, 1967;1: 212.
Boulos L. Flora of Egypt 1: 1-419. Cairo: Al Hadara Publishing; 1999.
Semmar N, Jaya M, Chemli R. Chemical diversification trends in Astragalus Caprinus (Leguminosae), based on the flavonoid pathway. Biochem Syst Ecol. 2001;29(7):727–38.
doi: 10.1016/S0305-1978(00)00105-8
pubmed: 11399359
Semmar N, Fenet B, Gluchoff-fiasson K, Hasan A. Jay M. Four new flavonol glycosides from the leaves of Astragalus Caprinus. J Nat Prod. 2002;65(4):576–9.
doi: 10.1021/np010328l
pubmed: 11975505
Semmar N, Jaya M, Farman M, Chemli R. Chemotaxonomic analysis of Astragalus Caprinus (Fabaceae) based on the flavonic patterns. Biochem Syst Ecol. 2005;33:187–200.
doi: 10.1016/j.bse.2004.06.003
Mahmoudi M, Abdellaoui R, Boughalleb F, Yahia B, Mabrouk M, Nasri N. Characterization of lipids, proteins, and bioactive compounds in the seeds of three Astragalus species. Food Chem. 2021;339:127824. https://doi.org/10.1016/j.foodchem.2020.127824 .
doi: 10.1016/j.foodchem.2020.127824
pubmed: 32882624
Abdallah WE, Awad HM, AbdelMohsen MM. Phytochemical composition, antioxidant and antitumor activities of some date palm pollen extracts. Egypt J Chem. 2023;66(5):425–34.
Zargoun AH, Mohammed AMA, Abdelshafeek KA, Ibansharrada AA, Alomari AA. GC/MS Analysis of Lipid Constituents and Antimicrobial Activityof Arum cyrinaicum extracts. Egypt J Chem. 2020;63(5):1–9.
Abdelshafeek KA, Rahmatalla AB, Muftah AH, Alderhami SA. GC/MS analysis of the oils and lipid constituents and evaluation of different extracts from Salvia fruticosa Mill. Seed Egypt J Chem. 2022;65(8):763–71.
Gonelimali FD, Lin J, Miao W, Xuan J, Charles F, Chen M, Hatab SR. (2018). Antimicrobial properties and mechanism of action of some plant extracts against food pathogens and spoilage microorganisms. Front. Microbiol., 2018;9:1639.
AbdelMohsen MM, Salah IA, Handoussa H, Mandour YM. Identification and quantitation of ursolic acid in Plectranthus amboinicus extract; molecular docking approach for its antiproliferative potential. Egypt J Chem. 2022;65(12):305–11.
Handoussa H, AbdAllah WE, AbdelMohsen MM. UPLC–ESI-PDA–Msn profiling of phenolics involved in biological activities of the medicinal plant Halocnemum strobilaceum (pall). Iran J Pharm Res. 2019;18(1):422–9.
pubmed: 31089377
pmcid: 6487433
Mandour YM, Refaat E, Hassanein HD. Anticancer activity, phytochemical investigation and molecular docking insights of Citrullus colocynthis (L.) fruits. Sci Rep. 2023;13:20038.
doi: 10.1038/s41598-023-46867-6
pubmed: 37973959
pmcid: 10654702
Salem MA, Farid MM, El-Shabrawy M, Mohammed R, Hussein SR, Marzouk MM. Spectrometric analysis, chemical constituents and cytotoxic evaluation of Astragalus Sieberi DC. (Fabaceae) Sci Afr. 2020;7:e00221.
Makboul MA, El-Shanawany MA, Abdel-Baky AM. Study of the lipid and flavonoid contents of Astragalus Cremophilos Boiss. Growing in Egypt. Bull Pharm Sci Assiut Univ. 1984;7(2):380–8.
doi: 10.21608/bfsa.1984.89868
Keskin C, Kaçar S. Fatty acid composition of root and shoot samples of some Astragalus L. (Fabaceae) taxa growing in the east and southeast of Turkey. Turkish J Biology. 2013;37(1):122–8.
Szabo K, Ranga F, Elemer S, Varvara RA, Diaconeasa Z, Dulf FV, Vodnar DC. Evaluation of the Astragalus Exscapus L. subsp. transsilvanicus roots’ chemical profile, phenolic composition and biological activities. Int J Mol Sci. 2022;23(23):15161.
doi: 10.3390/ijms232315161
pubmed: 36499484
pmcid: 9739471
Mabry TJ, Markham KR, Thomas MB. The systematic identification of flavonoids Spectrum. Berlin: Springer Verlage; 1970.
doi: 10.1007/978-3-642-88458-0
Tungmunnithum D, Thongboonyou A, Pholboon A, Yangsabai A. Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: an overview. Medicine. 2018;5:93.
Babich O, Prosekov A, Zaushintsena A, Sukhikh A, Dyshlyuk L, Ivanova S. Identification and quantification of phenolic compounds of Western Siberia Astragalus danicus in different regions. Heliyon. 2019;5(8):e02245.
doi: 10.1016/j.heliyon.2019.e02245
pubmed: 31453402
pmcid: 6700501
Sarikurkcu C, Zengin G. Polyphenol profile and biological activity comparisons of different parts of Astragalus macrocephalus subsp. Finitimus Turk Biology (Basil). 2020;9(8):231.
Salehi B, Carneiro JNP, Rocha JE, Coutinho HDM, Braga MFBM, Sharifi-Rad J, et al. Astragalus species: insights on its chemical composition toward pharmacological applications. Phytother Res. 2020;35:2445–76.
doi: 10.1002/ptr.6974
pubmed: 33325585
Shahrajabian M, Sun W, Cheng Q. A review of Astragalus species as foodstuffs, dietary supplements, a traditional Chinese medicine and a part of modern pharmaceutical science. Appl Ecol Environ Res. 2019;17:13371–82.
doi: 10.15666/aeer/1706_1337113382
Amiri MS, Joharchi MR, Nadaf M, Nasseh Y. Ethnobotanical knowledge of Astragalus spp.: the world’s largest genus of vascular plants. Avicenna J Phytomed. 2020;10:128.
pubmed: 32257885
pmcid: 7103437
Cerqua D’AvinoD, Ullah I, Spinelli H, Di Matteo M, Granato R. Beneficial effects of Astragalus membranaceus (Fisch.) Bunge extract in controlling inflammatory response and preventing asthma features. Int J Mol Sci. 2023;24(13):10954.
doi: 10.3390/ijms241310954
pubmed: 37446131
pmcid: 10342042
Khameneh B, Iranshahy M, Soheili V, Fazly Bazzaz BS. Review on plant antimicrobials: a mechanistic viewpoint. Antimicrob Resist Infect Control. 2019;8(1):118–46.
doi: 10.1186/s13756-019-0559-6
pubmed: 31346459
pmcid: 6636059
Nagarajan K, Ghai R, Varshney G, Grover P, Genovese C, D’Angeli F, Goel R, Prasad T, Kalaivani M, Teotia AK. Identification of Potent Bioassay guided Terpenoid and Glycoside Root fractions of Astragalus candolleanus against clinically significant bacterial strains. Int J Microbiol. 2022;4584799. https://doi.org/10.1155/2022/4584799 .
Georgieva A, Popov G, Shkondrov A, Toshkova R, Krasteva I, KondevaBurdina M, Manov V. Antiproliferative and antitumour activity of saponins from Astragalus glycyphyllos on myeloid Graffi tumour. J Ethnopharmacol. 2021;267:113519.
doi: 10.1016/j.jep.2020.113519
pubmed: 33137432
Ionkova I, Shkondrov A, Zarev Y, Kozuharova E, Krasteva I. Anticancer secondary metabolites: from ethnopharmacology and identification in native complexes to biotechnological studies in species of genus Astragalus L. and Gloriosa L. Curr. Issues Mol Biol. 2022;44:3884–904.
doi: 10.3390/cimb44090267